Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
about
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.The use of loss of constitutional heterozygosity data to ascertain the location of predisposing genes in cancer families.An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer riskEffects of measured susceptibility genes on cancer risk in family studies.Evaluation of a decision aid for families considering p53 genetic counseling and testing.Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Li-Fraumeni syndrome--a molecular and clinical review.TP53-Associated Pediatric Malignancies.Genetic segregation analysis of early-onset recurrent unipolar depressionFamily history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.Towards an understanding of the role of p53 in adrenocortical carcinogenesis.Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.Timing and context: important considerations in the return of genetic results to research participants.Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinomaP53 germline mutations in childhood cancers and cancer risk for carrier individualsLi-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumGenetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.Hereditary breast cancer in the Han Chinese population.Li-Fraumeni SyndromeIndividual-specific liability groups in genetic linkage, with applications to kindreds with Li-Fraumeni syndrome.Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53.Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives.Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts
P2860
Q33593066-16BC8C7F-B985-417C-8B05-C212CC2C932FQ33674332-1438CC27-5AA5-4DBB-94D3-0E23801D0EA5Q33682930-404EA87B-257B-4F7D-8012-D52783E6ACEBQ33905119-D9A3DA82-59F3-4E82-ACF5-ACF790688D3DQ34052361-AFA512C8-0077-4DD7-9260-60543CA5FE06Q34093171-B1B35DA2-DB95-4C90-9FCC-8ADEAE55CA54Q34324382-0E182662-F98C-4428-96FE-0FA71EBBF44BQ34324683-6AD79036-76DB-41E0-9B4C-656BB7502E3FQ34432117-A54C4AE9-B293-4994-8384-FB55B97D11C6Q35103165-E01D8FAD-1E5F-48FA-8919-7A9A26D9D139Q35250170-64EC3DFC-3AE4-494B-B125-08BB131B4B44Q35602170-6DA50BFE-827E-43C2-8571-EBF09E31260CQ35783751-207D3D18-B908-42A5-8A51-B4E2EC55218EQ36080648-BEC2CB1D-FB89-4FFF-B232-6A53C5E16A82Q36169808-BC49A391-5E6A-4606-BB4B-F2D6CDEC83E3Q36470928-1E00B6CA-B8D5-4EB4-ACB4-06EBF31E9372Q36508843-5F58AD72-7B2A-4856-B7D9-8FDE1BF1258EQ36621004-CBF29F65-8A23-4BBB-9769-B69D2E4059B8Q36672536-239DB9E1-30E1-4886-9BD4-63811BB1DDF2Q36843211-B8663C20-72B5-4EBE-A884-1CF76916C909Q36978755-CF63A8AB-9261-4036-926E-8027CAE9F4CAQ37032644-12E52623-5365-46E1-B818-2788E58148AEQ37361646-C83F6EC7-9094-4979-AF7F-901078FF4A89Q38764208-C421E724-2007-4152-9A1B-3CB834ECF02BQ39940539-92D6073D-C538-4E7C-B4C0-9534E645E346Q40096071-AD052AF7-38C4-4580-AB52-C69C6BDC5154Q40633720-01D940C6-C451-4463-B37C-60D9C5882CD8Q55380394-CE57811E-EE42-48CA-8336-32BC04398F31Q57165768-058979DA-585C-4243-AEF4-85CA108D5757
P2860
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@ast
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@en
type
label
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@ast
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@en
prefLabel
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@ast
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@en
P2093
P2860
P1476
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
@en
P2093
E D Lustbader
L C Strong
W R Williams
P2860
P304
P407
P577
1992-08-01T00:00:00Z